Fmoc-N-PEG7-acid

CAS No. 1863885-74-8

Fmoc-N-PEG7-acid ( —— )

Catalog No. M26960 CAS No. 1863885-74-8

Fmoc-N-amido-PEG7-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 29 Get Quote
50MG 42 Get Quote
100MG 67 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Fmoc-N-PEG7-acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Fmoc-N-amido-PEG7-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • Description
    Fmoc-N-amido-PEG7-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Autophagy; calmodulin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1863885-74-8
  • Formula Weight
    619.7
  • Molecular Formula
    C32H45NO11
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)CCOCCOCCOCCOCCOCCOCCOCCNC(=O)OCC1c2ccccc2-c2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gietzen K, et al. Comparison of the calmodulin antagonists compound 48/80 and calmidazolium. Biochem J. 1983 Dec 15;216(3):611-6.
molnova catalog
related products
  • D3-βArr

    D3-βArr is a positive allosteric modulator for thyrotropin receptor (TSHR) which initiates translocation of β-Arr 1 (EC50: 11.6 μM) by direct TSHR activation.

  • N,N,O-Tridesmethylve...

    N,N,O-Tridesmethylvenlafaxine is an endogenous metabolite.

  • Mirificin

    Puerarin has been investigated for the treatment of Alcohol Abuse.